Belite Bio Shorts Surge Ahead of Pivotal Q1 Print
BLTE heads into tomorrow's Q1 earnings with short sellers building positions aggressively — and a stock that has given back nearly 17% in a month. The sharpest signal heading into the May 20 report is the jump in short…